Here you will find all our clinical education resources from articles to recorded webinars, all supporting equitable access to funded medicines.
Health inequities in the detection and management of diabetes and its associated health outcomes are significant concerns in New Zealand. The first step to addressing inequitable health outcomes is knowing that they exist.
Read the HAH bulletin to find out more.
In this webinar, Dr Ryan Paul discusses the changes to type 2 diabetes care in 2021, including when and how to use SGLT2 inhibitors and GLP-1 agonists. You can watch the webinar here or in ELearning.
Downloadable empagliflozin patient information and a recent slide presentation can be found within this article.
If you're having trouble pronouncing the name of the newly funded SGLT2 inhibitor for type 2 diabetes, you're not the only one! Watch our video guide to learn how to pronounce empagliflozin.
Inequities exist in all aspects of diabetes care. In this article, Alesha Smith outlines some examples, proposes some actions, and explains where the new medicines fit in.
This activity has been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for up to 0.5 CME credits for the General Practice Educational Programme (GPEP) and Continuing Professional Development (CPD) purposes.
Late last year, PHARMAC announced the SGLT2 inhibitor empagliflozin (Jardiance®) and empagliflozin with metformin (Jardiamet®) will be funded for the treatment of type 2 diabetes under Special Authority.
Find out all you need to know about the Special Authority criteria.
In this webinar, Dr Alesha Smith discusses the development of He Ako Hiringa and presents our new interactive data tool, EPiC. You can watch this webinar here or in ELearning.
In this webinar, Dr Rinki Murphy discusses the issue of inequity in diabetes care. You can watch this webinar here or in ELearning.
In this webinar, Sandy Bhawan and Dr Emily Gill discuss how to improve medicine access equity in primary care. You can watch this webinar here or in ELearning.
The call for equity in healthcare is not new but it is louder than it has ever been before. This article shares the experiences of primary care clinicians around the country as they work to improve medicine access equity for patients. This article is part of a course, which is accredited by PSNZ for Group 2 points for pharmacists and endorsed by CNA(NZ) for 1.5 professional development hours for nurses. It is also suitable for professional development for general practitioners.
Do you need help improving your understanding of medicine access equity issues? In this video you will hear from a number of primary healthcare professionals who are working to improve equity outcomes in the services they provide to patients